Here are three stocks rated as buys with strong momentum for investors to consider today, October 23:
Top Buys for Momentum Investors This October
Structure Therapeutics Inc. (GPCR): This biopharmaceutical company has a Zacks Rank #1 and saw its earnings estimates rise by 8.1% over the past two months.
Price and Consensus for Structure Therapeutics Inc.
Structure Therapeutics Inc. Price and Consensus | Structure Therapeutics Inc. Quote
Shares of Structure Therapeutics gained 8.7% over the past three months, outpacing the S&P 500’s growth of 7.7%. The company has a Momentum Score of B.
Current Price of Structure Therapeutics Inc.
Structure Therapeutics Inc. Current Price | Structure Therapeutics Inc. Quote
Rush Enterprises, Inc. (RUSHA): This integrated commercial vehicle dealership has a Zacks Rank #1, with earnings estimates up by 4.9% over the last two months.
Price and Consensus for Rush Enterprises, Inc.
Rush Enterprises, Inc. Price and Consensus | Rush Enterprises, Inc. Quote
Rush Enterprises shares rose by 11.0% in three months, outperforming the S&P 500’s 7.7% increase. The company also has a Momentum Score of B.
Current Price of Rush Enterprises, Inc.
Rush Enterprises, Inc. Current Price | Rush Enterprises, Inc. Quote
Natera, Inc. (NTRA): This diagnostics company holds a Zacks Rank #1, with a 3.5% increase in its earnings estimate over the past 60 days.
Price and Consensus for Natera, Inc.
Natera, Inc. Price and Consensus | Natera, Inc. Quote
Natera’s stock rose by 13.0% in the last three months, significantly higher than the S&P 500, which gained 7.7%. The company has a Momentum Score of B.
Current Price of Natera, Inc.
Natera, Inc. Current Price | Natera, Inc. Quote
Discover the full list of top-ranked stocks.
Find out more about the Momentum score and its calculation here.
Research Chief Highlights “Most Likely to Double” Stock
The Zacks research team has published a list of five stocks that could gain 100% or more in the near future. Notably, Director of Research Sheraz Mian has a standout stock that is expected to rise the most.
This top choice represents a leading financial firm with a rapidly expanding customer base of over 50 million and innovative solutions, positioning it for notable growth. While not all recommendations yield positive results, this particular stock could exceed the performance of previous “Stocks Set to Double,” like Nano-X Imaging, which increased by 129.6% in just over nine months.
Free: View Our Top Stock and Four Runners-Up
Rush Enterprises, Inc. (RUSHA): Free Stock Analysis Report
Natera, Inc. (NTRA): Free Stock Analysis Report
Structure Therapeutics Inc. Sponsored ADR (GPCR): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
